Senate Democrats ask Pharma firms for details about Trump deals

Newsquawk Staff · 6 Mar 2026, 14:35 UTC

Senate Democrats ask Pharma firms for details about Trump deals.

What it means

Senate Democrats' inquiry into pharmaceutical firms regarding Trump-era deals could signal potential regulatory changes in the healthcare sector. This scrutiny may create uncertainty for investors and could impact related equities and overall market sentiment, particularly if any significant policy shifts are proposed as a result.

What our latest note said

US Market Open, 28 Oct, 10:34 UTC · what it led with

NQ futures outperform following SK Hynix's upbeat earnings.
DXY flat; NZD hit after the RBNZ unexpectedly held rates steady.

Read the whole note Free to read.

Newsquawk Daily

Get the next one free, by email.

What moved overnight, where stocks, bonds, currencies and oil stand, and what’s due today. Written by our analysts.

Both market-open notes, EU and US, every weekday. No account needed. Unsubscribe any time.

If you trade

This headline was on the Newsquawk live feed at 14:15 UTC.

Use the Platform opens our news terminal in your browser, with the live headline feed. It’s news, not a broker.

Use the Platform

Free. No signup, no card.

Case studies

Headlines that moved markets

FX headlines from our feed, and what the market did next.

US President Trump expected to remove some tariffs on Canada in a bid to help Senator Susan Collins, WSJ reports.
USD/CAD−0.2%
South Africa’s National Treasury says Inflation is expected to return to 3% target in 2029.
USD/ZAR−0.3%
Fed’s Waller (voter) says more rate hikes are likely needed to tame inflation, but there is flexibility over the pace and hikes do not need to be consecutive.
DXY+0.1%

See all 193

More on this story

Make Newsquawk a preferred source on GoogleSelect this to see Newsquawk more often in Top Stories when you search Google.

What it means

More on this story

Related headlines